Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NASDAQ:TLRY

Tilray Inc. (TLRY)

4.69
-0.16 (3.20%)
as of Aug 24, 2026, 4:05:26 pm Market Open.
91 watching
0
Investor Insights
star iconAug 24, 2026, 12:00 am

This summary was created by AI, based on 3 opinions in the last 12 months.

Tilray Inc. is currently facing challenges reflected in its recent financial performance. The company reported a revenue of $288 million, which represents a 6.6% decline from the previous quarter, indicating potential difficulties in maintaining sales momentum. Additionally, the gross profit decreased to $79 million, marking a significant 14.9% drop, which raises concerns about operational efficiency and market demand. Furthermore, an even sharper revenue decline of 32% was reported in another review, emphasizing the need for an in-depth analysis of the factors contributing to this downturn. However, it is noteworthy that social media mentions related to Tilray have increased by 28.2% in the past 24 hours, suggesting that there may still be interest and activity surrounding the company's brand despite the financial setbacks.

consensus icon
Consensus
Sell
valuation icon
Valuation
Overvalued
review icon
Similar
Cronos,CRON
DON'T BUY
It reports Monday. Pot stocks have been devastating. Since 2018, this has been all downhill. Let's see if the CEO can change direction.
BUY ON WEAKNESS
Bullish on medical marijuana. We will see legalizing banking in the US for the sector. There will be volatility. He sold into strength. Likes it here. Has lots of upside potential.
COMMENT
It will be a big industry that will be huge in the future. There is still 30%-50% upside in the future. The question should be whether you would add new money or not. If you do not want to , it is time to cash out.
DON'T BUY
There's lower highs and lower lows. He would look elsewhere for better potential.
DON'T BUY
He would not buy this. It collapsed from $350. Not the story he invests in. A long term story, hopefully with another couple years of losses yet to come. Too risky for him.
COMMENT
There is some downside pressure on HMMJ-T. At the $14 or $17 range there is resistance. Who knows what the effect would be if the government changes in October. [Caller asked about TLRY] He sees $34 as a target on TLRY-T as there is nothing to hold it higher.
Showing 16 to 22 of 22 entries